March 2, 2013 Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium
March 1, 2013 The advantages of frontotemporal degeneration drug development (Part 2 of frontotemporal degeneration: the next therapeutic frontier)
March 1, 2013 Global standardization measurement of cerebral spinal fluid for Alzheimer’s disease: an update from the Alzheimer’s Association Global Biomarkers Consortium
January 1, 2013 Understanding Placebo Responses in Alzheimer’s Disease Clinical Trials from the Literature Meta-Data and CAMD Database
December 23, 2012 Research and standardization in Alzheimer’s trials: reaching international consensus
January 12, 2012 Recommendations For Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research In Adult Oncology
